Air pollution exposure damages cellular energy production by impairing mitochondrial function and fatty acid metabolism, according to a study published on September 24 in Arteriosclerosis, Thrombosis and Vascular Biology. Researchers at UCLA Health identified novel blood biomarkers—long-chain dicarboxylate acids and acyl-carnitines—that reveal early biological tissue stress from contaminated air before chronic cardiovascular and metabolic diseases develop.
Yet, the precise intracellular pathways driving this pathology remained poorly understood. Seeking to address that missing information, the study was spearheaded by Jesus Araujo, MD, a professor of environmental health sciences at the Fielding School of Public Health and a professor of medicine at the David Geffen School of Medicine at UCLA. By tracking metabolic molecules in both animal models and human subjects, the research team pinned down the exact biological mechanism: the cellular machinery responsible for energy production becomes compromised when exposed to dirty air.
Mitochondrial Dysfunction and the Accrual of Cellular Stress
The primary driver in this disease cascade is the mitochondrion, often referred to as the cellular powerhouse. When ambient air pollution enters the body and damages these structures, cells lose their efficiency in breaking down dietary and stored fats for energy. This failure of fatty acid oxidation leads to an accumulation of intermediate metabolic breakdown products—specifically long-chain dicarboxylate acids (DCAs) and medium- to long-chain acyl-carnitines (ACs)—which then circulate freely within the bloodstream.
The buildup of these specific metabolites reflects hepatic oxidative stress and lipid damage. This inflammatory state in the liver acts as an early warning sign, subsequently advancing to chronic cardiovascular disorders, metabolic conditions like diabetes and dyslipidemia, fatty liver disease, and even cancer. Because clinical manifestations vary widely among populations exposed to environmental pollutants, healthcare providers have historically lacked predictive screening mechanisms to identify vulnerable individuals before irreversible organ damage occurs.
Cross-Species Analysis and Clinical Biomarker Discovery
To isolate these biological indicators, the investigative team executed a rigorous cross-species analysis utilizing plasma samples drawn from two prior observational efforts. In the preclinical model, mice were subjected to diesel exhaust inhalation over a controlled two-week period. To monitor how clinical markers changed over a 10-week period during the summer months of 2014 and 2015, a parallel human trial followed a group of 26 healthy, nonsmoking adults from Los Angeles who traveled to Beijing.
By meticulously cataloging individual metabolic molecules in both sets of blood samples, researchers observed identical patterns. Exposure to pollution resulted in substantial, measurable increases in circulating long-chain DCAs and medium-to-long-chain ACs across both mice and humans. Because these metabolites are well-established indicators of fatty acid metabolic deficits and mitochondrial injury, the data confirms that cellular energy disruption plays a foundational role in the early cardiovascular damage caused by poor air quality.
In Plain English: The Clinical Takeaway
- The Energy Deficit: Air pollution damages mitochondria—the cells’ energy factories—preventing them from properly burning fats and generating power.
- The Blood Markers: Unprocessed fats break down into specific molecules (DCAs and ACs) that spill into the bloodstream, serving as an early indicator of cellular distress.
- Early Detection Potential: Testing for these circulating biomarkers could soon allow doctors to catch pollution-induced tissue stress in healthy patients long before chronic heart or metabolic disease takes root.
Research Funding and Institutional Support
The study was supported by major public health and scientific funding bodies, ensuring independent academic rigor. Financial backing was provided by the National Institute of Environmental Health Sciences, the National Institutes of Health, the American Heart Association, the National Key Research and Development Program of China, and the National Natural Science Foundation of China. Alongside lead author Jesus Araujo, MD, the group of investigators consisted of Yan Lin, Xinghua Qiu, Rajat Gupta, Gajalakshmi Ramanathan, Xinchen Lu, Fen Yin, Oliver Fiehn, Junfeng (Jim) Zhang, Joel D. Kaufman, Yifang Zhu, and Michael Rosenfeld.
| Cohort Type | Exposure Model | Duration | Key Metabolite Finding |
|---|---|---|---|
| Preclinical Animal Model | Diesel Exhaust Inhalation (Mice) | 2 Weeks | Elevated long-chain DCAs and acyl-carnitines |
| Human Observational Trial | Travelers to Beijing (26 healthy, nonsmoking adults from Los Angeles) | 10 Weeks (Summer 2014 & 2015) | Identical elevation in circulating DCAs and ACs |
